Previous Close | 1.5400 |
Open | 1.5590 |
Bid | 1.5600 x 100000 |
Ask | 1.6020 x 100000 |
Day's Range | 1.5590 - 1.5590 |
52 Week Range | 1.1780 - 3.4860 |
Volume | |
Avg. Volume | 177 |
Market Cap | 72.445M |
Beta (5Y Monthly) | 1.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.6100 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 30, 2022 |
1y Target Est | N/A |
~ Achieved significant merger milestone with expiration of HSR waiting period ~ 2024 First Quarter Highlights: Generated net sales of ~$327 million and a GAAP net loss from continuing operations of $26.2 millionAchieved Q1 Adjusted EBITDA of $23.8 million with an improved EBITDA margin of 7.3%Delivered continued robust Spunlace performance with ~$5 million improved EBITDAImproved Composite Fibers EBITDA by ~$2 million, consistent with expectationsRecorded ~$9 million lower EBITDA in Airlaid Mate
(Bloomberg) -- Citigroup Inc. and Wells Fargo & Co. are preparing a $2 billion debt package to support Berry Global Group Inc.’s spinoff of the majority of its health, hygiene and specialties business with Glatfelter Corp., according to a person with knowledge of the matter. Most Read from BloombergBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsZuckerberg Asks for Patience After Meta’s AI Push Irks InvestorsTaylor Swift Is Proof That How We Critique Music Is BrokenMalay
EVANSVILLE, Ind., April 17, 2024--Berry Global Group, Inc. (NYSE: BERY) and Glatfelter Corporation (NYSE: GLT) announced today the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry’s Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business ("HHNF") with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.